USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI USA ‘26
      500+ Investors & Strategics
      See LSI USA '26 Attendee List
      Events Overview
      • Our Summits
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI USA ‘26
      • LSI Asia ‘26
      • LSI Europe '26
      Past Summits
      • LSI USA ‘25
      • LSI Asia ‘25
      • LSI Europe ‘25
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      February Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI USA '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • Our Summits
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI USA ‘26
  • LSI Asia ‘26
  • LSI Europe ‘26
Past Summits
  • LSI USA ‘25
  • LSI Asia ‘25
  • LSI Europe ‘25
  • Archives
Featured
Our Next Event
Register for LSI USA '26
350+ Investors & Strategics
See LSI USA '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
February Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI USA '26
Just Launched
Compass AI
Join our Next Event
LSI USA ‘26, March 16-20, 2026
Waldorf Astoria, Monarch Beach
Register Today
Compass AI
The medtech-specific AI
research platform by LSI
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. Engaging Clinicians in Venture Investing — How Can We Bridge the Gap? | LSI USA '25

Engaging Clinicians in Venture Investing — How Can We Bridge the Gap? | LSI USA '25

Join industry leaders from 46 VC, MedMountain Ventures, Mimosa Dx, and Controlled Delivery Systems as they discuss actionable strategies to effectively engage clinicians in venture investing and bridge the gap between clinical expertise and innovation.
Share social-facebook social-x social-linkedin
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI USA ‘26
LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Paul Slosar  0:05  
Well, thank you all for attending this symposium. I'm My name is Paul Slosar. I'm joined by four Well, joined by three. All of us are physicians. To the two to my left, to your right are physician founders, myself and Brandon are physicians turned venture capital. Everyone here is a clinician. There's nobody who went straight, at least to my knowledge, from medical school to B school or to VC school, if such a thing exists, but Henry Peck, who obviously is the energy behind this meeting, reached out to me, is my first meeting for LSI, and said, I'd love to have you join us, and by the way, I'd like you to moderate a panel. And so he put together this group. None of us have met before. We tried to get together, but people are busy. We've managed to string it together. But what I'd like to do first is have everybody introduce themselves, and then I'm functioning as the moderator as well as a participant. So we'll try to keep this pretty casual engaging. And so lemme just start with Ali, maybe you could just introduce yourself. What brings you here to the conference and what you're up to? 


Ali Golshan  1:32  
Yeah, my name is Ali. I'm an interventional radiologist. I've been in practice for over a decade. Got a couple clinics and surgery centers. We do primarily outpatient vascular with some embolization of wound care. And I have a startup in the superficial, venous and pelvic embolization space. And really just to support friends and meet with colleagues and business development, et cetera. We're not raising right now, but just a great call. Just a great conference to meet people and get together. 


Karen Cross  1:45  
Karen Cross, I'm a plastic surgeon by background, but I'm also a PhD scientist, so never envisioned myself in business as an academic surgeon, but here I am. I'm the CEO and co founder of MIMOSA Diagnostics. We are the first portable medical imaging technology for skin health or skin imaging, we actually look at the angiosomes of the skin and is skinny reperfusion injuries, mainly for wound care, pressure injuries, ICU monitoring for when you switch your ECMO lines, FDA cleared reimbursement code commercial. So again, not my, not the usual story, and not wearing I thought I would be but really loving this part of the journey I'm at LSI also just to be back keep people for our future investment warm, as well as some strategic partnerships and therapeutic partnerships.


Paul Slosar  2:32  
Branden 


Branden Rosenhan  2:33  
Awesome. Brandon Rosen, I'm a critical care physician, been a serial entrepreneur and turned into and started a small venture fund five years ago. And so we're in our second fund, and soon to be going to our third. So, you know, I say that I've been kind of on both sides of the table, in terms of being a founder, raising from venture, and now being on the venture side, looking predominantly we love technology, with PhD providers, PhD PhD experts, getting grants, non dilutive capital. And then we want to support, of course, physicians and their endeavors. And then I've worked full time as a critical care physician, in addition to the fund and my startups, until like this month. So yeah, that's I'm excited to be here. That's why I'm so smiling. Yeah. And so Paul slosar, I'm orthopedic spine surgeon. I practiced in the San Francisco Bay Area for 28 years. Was fortunate to be in the Bay Area, worked with a lot of venture and private equity firms, just doing due diligence, project based work, assessment of technologies, landed a couple of opportunities as advisor and even a chief medical officer role, and over the course of the 28 years, was associated with four companies that have exited. I had a knack for it, and I ended up going back to business school. I spun out of the bay area just two years ago, stopped practicing just two years ago, and co founded a venture capital fund. And our aim physicians Capital Fund is the is the name of the fund. Our goal is to try to address the issue, which is essentially the issue of our symposium today, about the relative absence of physicians and healthcare professionals in the venture ecosystem. And so we're appealing to not just physicians as as investors, but we're aiming at anybody along the healthcare continuum, because it's as all of us know who are here. It's complicated. A good idea doesn't always mean it's market viable. So today, what I'd like to do with this panel is explore one thing in very distinct, you know, contrast, I think, you know, if, if you look around the room, I presume there's physicians here, I know a couple are here. There's there's investors here, I presume there's founders here. But I'm going to try to draw a distinction with our panel from physician advisors, kind of project based consultants who might do due diligence for a venture firm. From actual general partners, limited partners, the relative paucity of them. So what I like to do is first ask Brandon, you know, why is it? Do you think Brandon that physicians are not a typical part of the venture ecosystem compared to maybe finance or technical you know, professionals? A great question. We start off training, which takes years and years and a decade to actually have a profession that where we get, you know, we get a salary that we can start paying off our loans. So I think we're busy. I think that we don't know this space very well, and we certainly don't understand, you know, how venture works. So that's, that's what most physicians I'm going to keep it simple. It's, we work hard. We have decades of training, and, you know, we're busy with practices. We're busy working. I mean, I was working, you know, 50 hours a week when I did my startup. And not everyone wants that. So it's hard work. It's hard work as a physician to transition to whether it's consulting, whether it's a startup, or whether it's on the investment side or venture side, and lemme turn to my founders and say, do med tech or Now I read my LSI program tech, med companies. I'm not sure how everything falls out. Do companies really want or benefit you as founders from physicians in the venture ecosystem. And maybe I'll start with Ali.


Ali Golshan  6:25  
I mean, it kind of depends on the individual. Yeah, if you have someone who's invested before been an early stage advisor for is well connected to industry, or is involved in early stage clinical trials and designs, et cetera, et cetera, they can be extremely helpful. Otherwise, they can be helpful as a potential customer, to give you insight. But you know, there is diminishing value in some advisors versus others, and I think that, like you all were saying, if it's someone that's seasoned and got into it later, or if they did an integrated MD MBA, or had a startup before they got into med school, I think their journey of familiarity with Medtech and venture starts earlier. So they might start at an earlier age, but you have to look for something unique. What do you think? Karen,


Karen Cross  7:08  
yeah, I mean, I think you know, back to what we were talking about in the beginning. You're, you're training to be, I was training to be a surgeon, so spending hours at the hospital, but also building my network. And it takes some time before you kind of get out there and people understand who you are, and then maybe the strategics start to bring you in and say, Could you give us some advice about x, y, z? So it does take time, if you're not connected into the business community. I didn't come from a business background to get exposed. You know, I never would have envisioned I'd be at a conference like this, for example, as an academic virgin, and I said that at the beginning. But then once you get exposed, you know, you can provide a lot of value. I think you can provide your opinion on whether this is a value piece of technology to the healthcare system. And people find you. They will find you if you put yourself out there, yeah,


Paul Slosar  7:57  
yeah. And the other, the other topic I want to kind of expand on a little bit is, you know, what are the barriers that exist in terms of clinicians and venture and how can we address these? I'm going to make an assumption. The panel, I hope, will not disagree with me, that we all kind of think it's a good idea in medical delivery, care, med technology, you could maybe make an argument against in pharma, do you really need physicians in that kind of granular space? But in terms of the the actual venture ecosystem of medical technologies, I think Brandon mentioned it before, some of the structural barriers that I see is just number one time. You know, most of us as patients don't want our physicians distracted by, you know, the potentially consuming aspects of venture. You know, there's a lot of work and very little return, you know, unless there's, there's an exit, which tends to be many, many years after the work begins. Literacy, you know, physicians have, and I have one of my other questions, but I'll throw it up now. You know, physicians are often given a reputation of not being very good at business, per se, and I'm not sure that that is necessarily accurate, but by the same token, most of them only get exposed to single investment opportunities, you know, the single check idea and and the last thing is awareness, right? They're not at meetings like this, unless they have a company that they're founding or are transitioning into, into the space. But maybe Brandon is as you as of now, as a physician turned venture capitalist, you could expand a little bit about how you talk to colleagues, physicians, or just healthcare professionals about venture and encourage them to lean in? Yeah, that's a great question. I think it's easiest to give a little bit of of how I got into this space. I think you're right. Time is a huge barrier. And then I think physicians are in their sort of their island. And you a lot. Of them want to work with themselves or with their partners, and so to get the business the business experience, you have to branch out of your out of your network. And so for me, it was a matter of spending more time. The barrier is also not just time in terms of when you have outside of clinical but what you're going to read and what you're going to spend your time. I mean, you wouldn't got an MBA. I mean, you're running businesses. And, I mean, I have to be honest with people when I tell them physicians, I'm like, I couldn't read the New England Journal of Medicine cover to cover every week because I started learning venture. I started watching listening to podcast. I started, you know, my own company, and started learning about patents. And so you know, it takes physician willingness and then an improved network, and then the ability to, you know, raise ways, raise awareness, start to make small investments with Angel groups, work with other people. There's enough now physicians interested that you can engage in that community, but you got to want to do it. And, you know, everyone has a great idea. I say about probably 80, 90% of physicians have a great idea, but you got to execute on it. It's really hard to do. Yeah. Well, what a great segue. You might have looked at my cue card here, but So now, as I pivot to my physician founders, is it your opinion? I'll start with Karen. Now, are entrepreneurial physicians potentially better venture capitalists, and when you as a founder are approaching funding sources, be it you know, syndicates, be it individual investors, do you find that physicians or healthcare professionals represent a an opportunity or a challenge?


Karen Cross  11:36  
Yeah, I think it's it's both, but we'll talk about the opportunity. So it's it again. The thing I learned very early is that it's not enough to have an idea. The ideas are great and they're they're innovative. But how do you become an entrepreneur and they're, they are different. Entrepreneurship is about adoption. So your technology can fit within the healthcare system. It's adding value to the healthcare system, but you also understand what value you bring. So I think you know, just differentiating that first, what's innovation? What's innovation, what's entrepreneurship, as I started, and again, I don't have a background in business, and I really, I don't have any business family members, but I put myself really when I realized it was going to build a business, I said, I have to learn about this very quickly. So my colleague, my office, was sort of long winded answer, but my office was close to the ICU, and there was an ICU doc in there who was managing 3 billion in PE assets. And I said, Why do you do this? Do you know, talk to me about this? And I started to learn from him, and I realized, Wait, hold it, I'm running my own business right now. I know how to run a business. I mean, I'm Canadian, and people think it's socialized healthcare. No, we run we run big practices, and we run big business. And I started to learn from him, and I realized, wow, I can add a lot into into both the VC world, but I learned a lot on how to take investment, how to protect the investment. So I think you know, the answer is, yes, there's opportunity. The challenges are a lot of times again, at the beginning, physicians or clinicians don the difference between an idea and innovation and entrepreneurship. So the challenge then becomes, there, well, you have this great idea, yeah, but how do you get it adopted? And I'm not sure to say about that, but I think in the beginning, I was a bit naive on how we were going to get here.


Ali Golshan  13:13  
The checks that I got from physicians that were sizable were from entrepreneurial physicians. So they were either people that were in this AI surgery center. They were an outpatient practice, outpatient Cath Lab, which is a business with often double digit million revenues and single million digit profits. Or they were part of a startup and had an exit before, so they had already kind of demonstrated the bug of being an outlier amongst physicians and being entrepreneurial. Or they were entrepreneurs that weren't necessarily entrepreneurial physicians or but were adjacent to health care innovation, or had a colleague that they could do due diligence through. And I think that if the person knows you, that's one degree of comfort. If they know the technology, that's another degree of comfort. And I think more and more physicians in some niches of medicine, like cardiology, interventional radiology, surgery, are starting to go out into ASCs, etc, and they're starting to have to manage businesses. And even though some practices are getting consolidated into physician employment, there are still other practices where people are shifting to entrepreneurship. And if you look in those silos, they've already kind of demonstrated that comfort. They're more likely to take a leap.


Paul Slosar  14:16  
Yeah, yeah. And there's, there's this may not just apply. You know, physicians are humans too, right? They're not just a completely different species. They may act like it occasionally, but, you know, I don't think that the issue about, you know, financial literacy, risk tolerance, etc, just applies to physicians. I think they get, we get molded, after a while, into being sole decision makers. We make a lot of decisions without a lot of CLA we might talk consult, but ultimately, we all have individual responsibilities, and if we don't understand something, I think there's often a tendency to pause and revisit and revisit, and which I believe carries over. I don't. That's completely unique. But I do think, As Brandon mentioned, by the time physicians get out and get capital that they might be able to deploy into venture, they're often, you know, well into the their their, you know, later to middle career years due to do the financial strains of training. But there's also, like a subcategory of physicians as it pertains to their specialties. You know this idea of of breaking down investors, and you might look at just people as investors, of not having a monolithic thing, it's an investor, a founder, etc. You have to kind of break that down, right? That that these are people, and if they're doctors, what kind of doctor are there? And maybe brand new could you coming from the intensive care unit, primary care, I would offer. It's more unusual in my experience to see docs from primary care versus the surgical or interventional specialties that tend to have a perimeter universe of surgery centers, entrepreneurial experience, MRI centers, physical therapy. You know there's this exposure to other revenue streams where primary care docs in the ICU, you're not running a business adjacent to the ICU. So I wonder if you could maybe break down how you view when you're talking to potential investors in your fund who are physicians. Do you have a different playbook, either by what specialty they are, their financial literacy, maybe their risk tolerance, etc. How do you kind of size them up before you take the meeting? Yeah, honestly, it's what I've told entrepreneur series. It's pretty straightforward. You go and ask everybody, right? So, I mean, there isn't, you know, going back to your other question to tie this in, is there's not much of a difference between those on this side of the the, you know, the the stage, and those of us, because is venture, you know, we're money managers, right? Which means I have investors. I raise money frequently, right? And they'll it's not different from what they're doing. And so when you go raise money from physicians, which I did for my first startup, and I had like 50 investors, right? Probably 30 of them physicians. So I didn't distinguish between who was a surgeon and who wasn't. I said, I actually want a hand surgeon. I want an orthopedic surgeon that has spine. I want a nephrologist. I want, and that's how I approach it. And anyone else that came to me to say, the more investment we get from physicians, the more we get different ideas out of disciplines. I'm not sure if that answered or gave some important insight. So all physicians, you know, honestly, like, for me, it's surgeons, in the way I think about it too, is no offense if there's any pediatricians. But like, when you're raising capital from, you know, high net worth people or physicians that have a great salary, even if they're not like net high worth because they just came out of fellowship. Usually, a physician that's interested in the stuff that goes into a venture group or goes to raise money, depending on the stage, can typically make a $10,000 investment if they're wanting to get into this. So you kind of start small, and then you work your way up. And then there's physicians that have larger practices later in their career, and they can write a $50,000 investment. So everyone, just like I tell entrepreneurs, go, you ask everyone, and the more you ask, the more chance you're going to get investments. So I'll kick this now over to Ali, a lot of physicians who are the entrepreneurial type. And Karen mentioned this too. You know, industry has a way of finding the entrepreneurial physicians. And entrepreneurial physicians finding industry opportunities. Physicians are often interested in being part of a company, advising, engaging. Sometimes they ask for pieces. You know, opportunities within the company which they should be reimbursed, however, is appropriate. But do you see? You know professional investing, you know strategic venture investing as an opportunity for physicians to get exposed to more advisory opportunities to see more companies. You as a founder, obviously, as a physician, you don't need a ton of help, maybe, if it's completely outside of your area of expertise, but there are a lot of companies who are, you know, who are physicians are absent, in my opinion, way too long in their life cycle before they get some real input. So do you see of venture capital as an opportunity for docs who are trying to get in, dip their toe in the pool, a way of entree into this universe? Yeah,


Ali Golshan  19:32  
I think if you take the approach of teaching courses for strategics, getting on the podium, investing and advising, then you kind of approaching it from multiple angles, and so then you bring a lot of value to the venture firm or the startup as a potential advisor, because you're a key opinion leader. You have contact with strategics, you have contract with capital. You're adept at doing due diligence on deals, and you have a podium presence that then I think you bring multiple value. Your streams, rather than just saying I'm a small check or, Hey, no, a guy at the strategic and then you're also looking at things from multiple angles, like, I have a couple of buddies that are just close friends from back in the day, and they'll email me to look at a deal. And now that I've invested, I've started, I've advised, I've spoken on the podium. I know how to look at the different, you know, boxes on the risk strata, and I can tell them relatively quickly, you know, from a clinical perspective, like, would I use this or not? And I have a surgery center, I buy stuff, I know what it costs, I know what I get paid for it. So I'm not living in a place where I'm not making the decision of what the purchase and what the reimbursement is. So I can check a lot of those boxes. So I think the more of those boxes you check, the more value you bring as an advisor.


Paul Slosar  20:40  
And from a personal perspective, getting back to the to the physicians Capital Fund, very similar to what Ali is mentioning, and I believe Brandon and I have had similar conversations. I see opportunity for founders, for companies that do not have you know physician leadership or physician founders, but are aiming in med tech adoption to tap into ecosystems, and I don't want a fund of just doctors, right? I mean, that's another problem, right? We need people who can look at deals, Surgery Center, supply chain, do the due diligence on the intellectual property, financial analysts who has experience running a hospital system, would this fly? What are the barriers being able to see around corners? I think the most difficult aspect of in my experience, of with various companies in Medtech is that adoption into the workflow, inserting yourself into inserting your product into the healthcare delivery system in a way that both raises the outcomes maybe improves cost efficiency opportunities. It's very difficult to get a company far down the runway without some input from from physicians or other people along along that health care chain. I want to come back to something that Karen mentioned earlier about networking, and I think physicians are terrible at networking. I mean, you all, whoever you know, well, anybody who's at this meeting is good at networking. But that being said, Our colleagues are awful at it. And I have my own reason. I have my own thoughts about why. I mean, we do get inundated with human contact all day and all night and in the ER, but maybe you could talk a little bit about how you see building out a network for physicians who either wanna get into investing, wanna get into a parallel opportunity in medicine, like business, and how you use your network to build your company.


Karen Cross  22:40  
Yeah, yeah. And the first thing I'll say is a physician is willing to write you a check into your company. It's really a form of a compliment. They believe you have something, and they're willing to take their hard earned money and invest it into you for something different. So just to sort of set that stage on the networking side again, the first way I started was with strategics. So when they realized I had expertise in wound care, I was doing a lot of limb preservation and salvage, I got invited into advisory boards. So the first way I started was through advisory boards. I started medium size. Then I started, you know, global multinationals, and I just looked at, you know, what are you doing that got to help me just understand business and that piece, the second thing I did is there are physician groups that do group investments, and I found them, and in Canada, it's a group called Halo health. And I said, Okay, how can I get more involved here? How can I first get involved with companies and give them advice? So then I said, Okay, let's give you advice about how to take your product to market, yeah,


Paul Slosar  23:41  
and then on an educational level, not just self promotion, yeah? Exactly. Doctors like that, of course, yeah. They don't want you just promoting your thing. They want you to educate them. Then they'll take you seriously. 


Karen Cross  23:54  
Well, I think it's just really like helping them understand, like this product. You know, have you thought about this area of medicine, because this would fit really well. And have you thought about this? Because there's a workflow problem here, so it's just really giving them some advice. And then I took the next step and said, Okay, now, how do I invest so you can start slow, you know, again, I didn't understand the space as well, and now I feel very comfortable in it. And that was sort of, personally how I started, and clearly also invested in myself and but yeah, there are people who can help you. And I think networking is really important. We do it in medicine, we find our colleagues, we learn new techniques. It's the same thing in business. You just have to have the courage to ask questions and be curious,


Paul Slosar  24:40  
yeah, and I'll have Brandon touch on this too. But I think that one of the key opportunities with physicians and maybe anyone who has, you know, a very specialized occupation, who may be blind to. The investing side in the equation, they kind of get approached people with high net worth for single check investing. I have, we all have, I think, and you know, it's it, when you do the math, it's just kind of, you know, no offense, but it's just, you know, it's really dumb like to write a single check. It's one roulette chip on the table. And when I just speak to that to physicians about because they don't understand what adventure is. They don't get it that it's a pool of money that goes into 1518, companies, whatever the fund raises. You know that number one is just kind of a basic definition that helps them. But the second thing that I'd like maybe Brandon to touch on is the opportunity of from an education perspective and a network perspective, what are things that people who are looking in venture, you me, you know others, Ali said he's never going to be in venture. Maybe. Karen well after but, but how do we educate our peers? Is that a good way? And how do we encourage them to, you know, look up instead of looking down in terms of their network, opportunities of business, if they're interest, yeah, again, it's, you mentioned networking. You mentioned education and learning. I mean, in in raising money for me now, as I go to larger, larger investors and family offices, we're targeting a bigger fund. You know, the old adage is, if you ask for money, you get advice, and if you ask advice, you can get money. And so, and then what you also need to enter. So you go and you listen to people. If a lot of you are probably entrepreneurs, you're raising money. I don't know if there's a ton of physicians in here, but you go and you listen, and if you're going to physician, potentially investors. Again, you know, we're sort of egotistical. We think we know what we're doing, especially in the healthcare space, whether it's just this device or this AI component of some other product. You ask a lot of questions, learn, build that network around the physicians, and then you can get, you know, interest. And again, physicians like education, you know, it's not boredom. But I mean, you know, I joke that a monkey could do critical care, because you only can have, like, five or six therapies. So after eight years there, I'm like, Okay, what else do I want to learn? What else do I want to do? And so as entrepreneurs, you should do the same thing. You should go to the investors, and you should say, Listen, let me listen. Let me teach. Let me learn. From you other potential investors, CFO people, we brought a CFO and an experienced distributor partner on our fund, right? There's three of us physicians in our fund and one operator, and we needed that fourth tire on the car to really deliver what we needed. And so it's the same thing for you entrepreneurs. You listen, you go get it, lots of a lot of advice, and you build that network relationship. And again, I don't know if it answered the question, but yeah, no, there's no, no answer. Ali, do you have any, any comments about the best way to bring healthcare professionals? And I'm using, you know, the broader definition, because there's a lot of people who are in the healthcare delivery chain, into venture and, and maybe, you know, less, into the idea of of single check investing.


Ali Golshan  28:09  
Yeah, I like, like you were talking about going to groups. I have a colleague who has funded several startups and on several exits, and a lot of his money comes from a couple of groups, ortho, Gi, pulmonology. They know each other. They trust each other. They can do diligence the deal. And then instead of getting one check for $1 you get one check for $50 or, you know, whatever the multiple is. And it sort of makes the approach simpler. You can go to Angel groups as well, but anytime you can get in front of a large group of individuals that have already worked together in the past, that trust each other. I think it's shotgun approach, and then also going to, like you telling docs to come to these conferences, go to their conferences. You know what I mean? Learn their ecosystem, their environment, their language, etc. Know what their pain points are like, if you're trying to invest in things that they care about. From a clinical perspective, they might be more excited, because then you're not only taking their money, but you're potentially providing them a solution, or enabling them to be part of the solution where they think there's a shortcoming, you know, speaking their language. I think Same difference. You know, listen both ways. Great,


Paul Slosar  29:15  
great. Anything to add on that. Karen,


Karen Cross  29:17  
just cross pollination. We need to start to see more of that in the networking where the two worlds are crossing over.


Paul Slosar  29:23  
Yeah, and, and I, in the context of the company, I was the Chief Medical Officer for which was an 11 year run. It was a very disruptive technology. I was on the podium quite a bit on the on the spine circuit, as it were. And so I had a lot of, you know, engagement with societies. And the challenge I see to getting physicians literate in the financial side of it is that the societies kind of prohibit or frown upon, and I'm, you know, any any opportunity to introduce. Yeah. I mean, unless you want to talk about their RV use, right, and what your, you know, your qualities are, right? The stuff that has no, no application, no one even understands either of those numbers. But when you try to say, Hey, I'd like to bring a symposium, you know, no commercial aspect to it, to a physician academic, which is where they congregate. They need the CMEs. They need their medical credits. You can't get on. It's very difficult. You have to cloak it. I'm getting better at cloaking my my talks, and I'm not just Hawking. I don't even mention my fund at that. I just say to your point, hey, it would be good if we explained, like, what's the difference between being a an entrepreneur, a founder or an entrepreneurial physician who might lean in and advise companies, just kind of breaking the ice. So I don't know if, if you have any experience trying to break into the professional societies, the medical society, 


Branden Rosenhan  30:54  
I love that you brought that up because Ali said it perfectly, you, you know, so like, again, go to their societies. So society, critical care medicine I just came from, and they actually did a really nice job of bringing in an early day for physician entrepreneurs. But there were a number of entrepreneurs, you know, operators, engineers, that came even if it was like, here's my alpha or, here's my beta device. It's like, you know, it looks like this. It's not really going to be like this. It's going to be like this. And, I mean, I had dinner last night with one of the, one of the the founders that came to that conference. And now there's significant interest on both ends, right? Like Us is investing him as needs, needing advisor. So I love that you guys, like, really hit something and nailed it. That if you leave here, you know, we only can remember three pearls. Remember that that go to those other conferences. Look at what your space is. There's cardiovascular conferences. You've probably been s, I r, s like, right? And so there's that that's an incredible opportunity, I don't know about, you know, maybe this is something for you, is to go to now orthopedic conferences and say, look, let's have an Innovation Day, before, yeah. And let's bring in all these orthopedic operators, experts, engineers. So, I mean, you guys already nailed it. So I just over, I just talked too much about it. 


Ali Golshan  32:09  
The society meetings tend to be a little more conservative, sure. And so sometimes there are these conferences that are had by just the old school guy that knows everybody that matters. And you go, and you're like, holy smokes, like all the luminaries are here. It's a chill weekend. No one's bothering them. Dude, sit down and have a 30 minute conversation with the guy that invented the thing and the other thing and the other thing, and like that kind of access is not reproducible. And if you want to know what those conferences are, just like, find me or somebody else online and message me, and I'm happy to tell you where and when they are, and the dues are cheaper, and the hotels are nicer, and there isn't, like, 10,000 people running around trying to figure out what CT scanner they want to buy. Those are the like, the gems, the society meetings, I think are, like, a reasonable way to get the pulse. But, you know, they're very distracting, and they're very distract everybody. Heavy hitters are coming to those anymore because they don't care. Or yeah, semi retired. They're doing their thing. They're coming for their buddy that their pals with from back in the day. Out of respect, the little gentleman's are the ones to go to.


Paul Slosar  33:07  
No. That's That's great advice. I'm we can this is an open conversation. If anybody from you know the audience has any comments or questions, you know the mic is open, feel free to jump in the one of the, one of the things that that I'll pick up on is, is that the, you know, the docs are often averse to being approached. You know, they get inundated with new widgets, new drugs, new this many sign many who's have signs on the door, no reps, you know. And even they like to bring lunch, the staff gets upset. But I think that idea that they're there, they create a wall, presents a challenge to anyone who is, who is trying to approach docs, unless you're offering them, you know, an equity opportunity in your company, right then they might, might take the meeting. But in terms of of trying to get physicians into the investing world, which is what very much I think all of us are the founders benefit. I think as long as, as as Ali said, they don't get too many Bossy Pants doctors involved. You know, with with physician founders, they have a little bit more, but they can also be helped by other physicians or other professionals in the healthcare stream. Most of the companies, as I said, that I see, have this, you know, gap, or they might have a physician who's ancient and you know that they they brought on because it's somebody's, you know, dad that they knew and not in the in the mix of it anymore. I think those of us who are trying to in, I'm personally trying to increase physician autonomy, restore some agency to them, because a lot of them are burning out and it's no good. And I think personally, venture investing is an opportunity. Opportunity to do something in parallel to still practicing. You can be a limited partner in a venture fund. You don't have to have any responsibility. But if you want to lean in and say, Hey, I'd love to do help with the due diligence on that deal, learn the trade. I think there's a great you know, they, they tend to gravitate towards that opportunity. They're not usually super hands off, and they're risk averse if they don't make the decision like I think paradoxically, even though it's not mathematically sound reasoning, the single check investment is, is typical. You know, they're very used to signing their names, right? So, okay, I did my own due diligence. I talked to a couple people. Versus the venture ecosystem, where you can call three different venture firms. You do the full intellectual property analysis, competitive landscape. You have documents, you have term sheets. You know, single check investing doesn't appear. So I think that physicians have an opportunity who want to get involved in venture if you make the number approachable. You know, a lot of venture firms on the coast where I came from, the minimum investment, you know, might be $250,000 that doesn't fly for most physicians, except, you know, a few so on a more democratic basis, trying to make it more accessible, but also giving them the idea they can be doing something in parallel to their medicine that may have an opportunity. Maybe somebody like Karen calls and says, you know, I'm the CEO. I need a CMO. I need a fractional CMO, right? I mean, there's, there's opportunities, I think, in this ecosystem, to feather in docs who are interested and and might be good additions to the team. So we're kind of winding down, as I said, if anybody has any comments or questions, jump up. We'll pause, but maybe I'll just let kind of each person leave you with whatever you know, kind of thoughts in terms of how they view the physician clinician ecosystem of of investing and, and, and what, when they think it's a good idea, a bad idea, and, and how should we move forward? 


Ali Golshan  37:01  
Just find the docs that have been successful entrepreneurially and clinically in your space, and ask them what they think of your idea. And like you said, listen, and if they have something to say, positive or negative, if they have nothing to say, then, well, whatever. But if they have something positive or negative to say, and they seem interested or engaged, then, you know, engage with them further a conference. Conferences, etc, get to know them, see if they're going to be a pain or they're going to be added to value, and if it makes sense, then they'll offer or you can just ask


Paul Slosar  37:30  
Karen


Karen Cross  37:30  
Yeah. So again, as an academic surgeon with a full scientific lab, just want to highlight that Academic Surgeons or academic clinicians can be investors. You just declare your conflict of interest. So if anyone is an academic in the room or is listening, you just have to be like conscious of your bias. I think, just ask questions, be curious, put yourself around people who are in the space. And again, my friend and colleague, he taught me a lot. In fact, I got a big book about entrepreneurial finance as a gift one year for Christmas. 


Paul Slosar  38:02  
Yeah, being a doctor, being a doctor, you actually read it,


Karen Cross  38:06  
and I actually read it, because why? You know, again, it hit me when I think I put on 15 arms, I did eight craniofacial cases that were over 14 hours as a trauma plastic surgeon, and while I was running the lab and the company and everything else, and I said, You know what? We're kind of bored. I want to grow, and this is what I want to grow into. So you can find those clinicians that are like that. In fact, I think there's more that are coming that are just saying, hey, like, I want to challenge myself. We went into medicine because we like to evolve, not because we like to stay still, not true for everyone. But I'll just say, find those people who are looking to grow and evolve and get them interested, let their appetite. And I mean, you'll, you'll have them invested for life in lots of ways.


Paul Slosar  38:49  
All right, that's hard to follow. Good luck. 


Branden Rosenhan  38:51  
So I think a lot of our viewers, if I can, I'll do this in 10 seconds. If I can expand your network, talk to your cousins, they know a doctor. And so if you're trying to raise capital, you know, from funds that are physicians, it's hard, but from a lot of individuals, get advice, but you got to go around the corner. You can't just look at the wall and say, I can't get raise money. I can't raise money. Go around the corner, ask your cousin, your neighbor, which doctors they know, and you got to work hard from there. Sorry, it's 20 seconds. 


Paul Slosar  39:20  
Oh, we're down to eight, yeah. And so I will leave it that the idea that you touched on that that continuing to evolve. I think in many ways, physicians get to a point and they get out of school after, you know, 100 years, and then their job often is the same job for the next 30 years. It might be the same clinic, might be the same desk, and many of the people in this room by 40 or 50 have had three or four companies. They've had three or four roles. They've continued to evolve and challenge. Our challenge is all front loaded, and I think there is a certain aspect of boredom or failure to evolve that I hope this opportunity. D allows them. So if you have people, friends, family, individuals in clinical care who want to lean in, have them reach out to any of us. I mean, we're clearly very approachable and and we'd love to have the company. So on behalf of our panel, I want to thank you all for attending and hope it was productive.